JPRN-UMIN000010923已完成未知
A clinical phase II study assessing the safety and efficacy of readministration of bendamustine monotherapy or bendamustine/rituximab for relapsed low grade B cell non-Hodgkin lymphoma or mantle cell lymphoma patients previously treated with bendamustine containing chemothearpy - Assessment of the safety and efficacy of bendamustine retreatment
KEIO BRB Study Group0 个研究点目标入组 38 人开始时间: 2013年6月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 38
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. patients who are pregnant/female patients who are unwilling to take prevention measures for contraception during treatment 2. patients with active cancer 3. patients wih mental illnesses that the treating physician judges difficult to participate in the study 4. patients with circulating tumor cells > 25,000 /uL 5. patients with severe allergic reaction to medication 6. patients with active infectious diseases 7. patients who are positive for HBs antigen or HBV-DNA 8. patients who are judged inadequate to participate in the study according to the treating physician
研究者
相似试验
招募中
2 期
A Phase 2 Study of MK-3475A in Japanese Participants with Recurrent or Metastatic (R/M) or Locally Advanced (LA) unresectable Cutaneous Squamous Cell Carcinoma (cSCC)JPRN-jRCT2041230074Koh Yasuhiro19
招募中
2 期
Study to assess the Safety and Efficacy of Bacteriophage in the treatment of Diabetic foot infection.CTRI/2023/11/059899TechnoPhage
进行中（未招募）
不适用
A phase II clinical trial to evaluate the safety and efficacy of interferon gamma in elevating frataxin levels in Friedreich ataxia patientsEUCTR2012-001881-14-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA
已完成
不适用
A Phase 2 clinical trial to evaluate the safety and efficacy of cone beam CT guided video assisted thoracoscopic partial resection for impalpable small pulmonary nodulesmalignant pulmonary noduleJPRN-UMIN000030388General Thoracic Surgery, Chiba University Hospital20
进行中（未招募）
1 期
Study of an Artificial Human Skin Medicine for Patients With Basal Cell Carcinoma Undergoing Reconstructive Surgery.CTIS2024-515235-29-00Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud15